(Reuters) – Laboratory Corporation of America Holdings reported a 102% jump in quarterly profit on Thursday, driven by recovery in its non-COVID-19 testing business and strong demand for its drug development services.
Net income attributable to the company rose to $467.4 million, or $4.76 per share, in the second quarter ended June 30, from $231.6 million, or $2.37 per share, a year earlier.
(Reporting by Amruta Khandekar in Bengaluru; Editing by Shailesh Kuber)
